Yale Cancer Center has launched the Yale Center for Immuno-Oncology. The new center will build on Yale Cancer Center’s international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies. It is a partnership between Yale Cancer Center and the Department of Immunobiology at Yale University.
“This new center gives us the chance to work more collaboratively and efficiently with our world-renowned scientists and faculty to address scientific questions in immuno-oncology,” said Roy S. Herbst, MD, PhD, Chief of Medical Oncology at Yale Cancer Center and Interim Director of the Yale Center for Immuno-Oncology. “We hope we can transform the way we treat people affected by cancer by generating research advances more quickly in this groundbreaking field.” ■
